Subarachnoid Hemorrhage Recovery And Galantamine



Status:Recruiting
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - 75
Updated:4/3/2019
Start Date:September 2016
End Date:September 2019
Contact:Huimahn Choi, MD, MS
Email:Huimahn.A.Choi@uth.tmc.edu
Phone:713-500-5638

Use our guide to learn which trials are right for you!

A Pilot Parallel Double-Blind, Randomized Trial of Galantamine for Subarachnoid Hemorrhage

The purpose of this study is to examine the effects of the study drug--Galantamine—on
patients with subarachnoid hemorrhage (SAH). The study will examine how patients with SAH
will tolerate the study drug and how it may improve brain functioning in patients after SAH.


Inclusion Criteria:

- Spontaneous subarachnoid hemorrhage

- Presentation to hospital within 72 hours of symptoms

- Fisher grade 3 hemorrhage (thick subarachnoid clot) on initial computed tomography
(CT) scan

- Hunt and Hess grade 1-5 at time of randomization

- Presence of a cerebral aneurysm on computed tomographic angiography (CTA) or Angiogram
for which clipping or coiling is possible

- Ability to obtain medication within 36 hours of presentation

Exclusion Criteria:

- subarachnoid hemorrhage (SAH) due to causes other than aneurysm rupture (trauma,
arteriovenous malformation (AVM), mycotic aneurysms, Moyamoya)

- Pre-existing disability with modified Rankin Scale (mRS) score ≥2,

- Renal disease as defined by creatinine clearance less than 9 milliliters/min

- History of severe hepatic impairment (Child-Pugh score of 10-15)

- History of chronic obstructive pulmonary disease (COPD) or asthma

- History of dementia

- Co-morbid conditions likely to complicate therapy, including clinically significant
arrhythmia, acquired immune deficiency syndrome (AIDS), autoimmune disease,
malignancy, and expected mortality within 72 hours

- Expected mortality within 72 hours as determined by PI, treating neurointensivist and
neurosurgeon. (Clinically manifested by no attempt at securing aneurysm)

- Females who are pregnant.
We found this trial at
1
site
7000 Fannin St
Houston, Texas 77030
(713) 500-4472
Phone: 713-500-5638
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
?
mi
from
Houston, TX
Click here to add this to my saved trials